Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitarism ENEA rare observational (HEROS) study.


Journal

Pituitary
ISSN: 1573-7403
Titre abrégé: Pituitary
Pays: United States
ID NLM: 9814578

Informations de publication

Date de publication:
Dec 2022
Historique:
accepted: 22 09 2022
pubmed: 20 10 2022
medline: 23 11 2022
entrez: 19 10 2022
Statut: ppublish

Résumé

Central Diabetes Insipidus (CDI) is mainly associated with structural pathologies of the hypothalamic-pituitary area. Etiologies underlying CDI are identified in most patients, however idiopathic CDI is reported in 13-17% of cases after excluding other etiologies. The Hypopituitarism ENEA Rare Observational Study (HEROS study) retrospectively collected data of patients with idiopathic CDI from 14 pituitary centers in 9 countries. The cohort included 92 patients (59 females 64%), mean age at diagnosis was 35.4 ± 20.7 years, and a mean follow up of 19.1 ± 13.5 years following CDI diagnosis. In 6 women, diagnosis was related to pregnancy. Of 83 patients with available data on pituitary imaging, 40(48%) had normal sellar imaging, and 43(52%) had pathology of the posterior pituitary or the stalk, including loss of the bright spot, posterior pituitary atrophy or stalk enlargement. Anterior pituitary hormone deficiencies at presentation included hypogonadism in 6 (6.5%) patients (5 females), and hypocortisolism in one; during follow-up new anterior pituitary deficiencies developed in 6 patients. Replacement treatment with desmopressin was given to all patients except one, usually with an oral preparation. During follow up, no underlying disease causing CDI was identified in any patient. Patients with idiopathic CDI following investigation at baseline are stable with no specific etiology depicted during long-term follow-up.

Identifiants

pubmed: 36260240
doi: 10.1007/s11102-022-01277-1
pii: 10.1007/s11102-022-01277-1
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

982-987

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Masri-Iraqi H, Hirsch D, Herzberg D, Lifshitz A, Tsvetov G, Benbassat C, Shimon I (2017) Central diabetes insipidus: clinical characteristics and long-term course in a large cohort of adults. Endocr Pract. https://doi.org/10.4158/EP161555.OR
doi: 10.4158/EP161555.OR pubmed: 28225310
Imura H, Nakao K, Shimatsu A, Ogawa Y, Sando T, Fujisawa I, Yamabe H (1993) Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus. N Engl J Med 329(10):683–689
doi: 10.1056/NEJM199309023291002 pubmed: 8345854
Arima H, Azuma Y, Morishita Y, Hagiwara D (2016) Central diabetes insipidus. Nagoya J Med Sci 78(4):349–357
pubmed: 28008190 pmcid: 5159460
Garrahy A, Moran C, Thompson CJ (2019) Diagnosis and management of central diabetes insipidus in adults. Clin Endocrinol 90(1):23–30
doi: 10.1111/cen.13866
Refardt J (2020) Diagnosis and differential diagnosis of diabetes insipidus: update. Best Pract Res Clin Endocrinol Metab. https://doi.org/10.1016/j.beem.2020.101398
doi: 10.1016/j.beem.2020.101398 pubmed: 32387127
Masri-Iraqi H, Hirsch D, Herzberg D, Lifshitz A, Tsvetov G, Benbassat C, Shimon I (2017) Central diabetes insipidus: clinical characteristics and long-term course in a large cohort of adults. Endocr Pract 23(5):600–604
doi: 10.4158/EP161555.OR pubmed: 28225310
Maghnie M, Cosi G, Genovese E, Manca-Bitti ML, Cohen A, Zecca S, Tinelli C, Gallucci M, Bernasconi S, Boscherini B, Severi F, Aricò M (2000) Central diabetes insipidus in children and young adults. N Engl J Med 343(14):998–1007
doi: 10.1056/NEJM200010053431403 pubmed: 11018166
Di Iorgi N, Allegri AEM, Napoli F, Calcagno A, Calandra E, Fratangeli N, Vannati M, Rossi A, Bagnasco F, Haupt R, Maghnie M (2014) Central diabetes insipidus in children and young adults: etiological diagnosis and long-term outcome of idiopathic cases. J Clin Endocrinol Metab 99(4):1264–1272
doi: 10.1210/jc.2013-3724 pubmed: 24276447
Hockaday TDR (1972) Diabetes insipidus. BMJ 2(5807):210–213
doi: 10.1136/bmj.2.5807.210 pubmed: 4553944 pmcid: 1787920
De Bellis A, Colao A, Bizzarro A, Di Salle F, Coronella C, Solimeno S, Vetrano A, Pivonello R, Pisano G, Lombardi G, Bellastella A (2002) Longitudinal study of vasopressin-cell antibodies and of hypothalamic-pituitary region on magnetic resonance imaging in patients with autoimmune and idiopathic complete central diabetes insipidus. J Clin Endocrinol Metab 87(8):3825–3829
doi: 10.1210/jcem.87.8.8757 pubmed: 12161517
Pivonello R, De Bellis A, Faggiano A, Di Salle F, Petretta M, Di Somma C, Perrino S, Altucci P, Bizzarro A, Bellastella A, Lombardi G, Colao A (2003) Central diabetes insipidus and autoimmunity: relationship between the occurrence of antibodies to arginine vasopressin-secreting cells and clinical, immunological, and radiological features in a large cohort of patients with central diabetes insipidus of. J Clin Endocrinol Metab 88(4):1629–1636
doi: 10.1210/jc.2002-020791 pubmed: 12679449
Maghnie M, Ghirardello S, De Bellis A, Di Iorgi N, Ambrosini L, Secco A, De Amici M, Tinelli C, Bellastella A, Lorini R (2006) Idiopathic central diabetes insipidus in children and young adults is commonly associated with vasopressin-cell antibodies and markers of autoimmunity. Clin Endocrinol 65(4):470–478
doi: 10.1111/j.1365-2265.2006.02616.x
Czernichow P, Garel C, Léger J (2000) Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus. In: Hormone research, vol 53. S. Karger AG, Basel, pp 61–64.
De Buyst J, Massa G, Christophe C, Tenoutasse S, Heinrichs C (2007) Clinical, hormonal and imaging findings in 27 children with central diabetes insipidus. Eur J Pediatr 166(1):43–49
doi: 10.1007/s00431-006-0206-0 pubmed: 16944241
Corredor Andrés B, Muñoz Calvo MT, López Pino MÁ, Márquez Rivera M, Travieso Suárez L, Pozo Román J, Argente J (2019) Thickening of the pituitary stalk in children and adolescents with central diabetes insipidus: causes and consequences. Anal Pediatr 90(5):293–300
doi: 10.1016/j.anpedi.2018.05.002
di Iorgi N, Napoli F, Allegri AEM, Olivieri I, Bertelli E, Gallizia A, Rossi A, Maghnie M (2012) Diabetes insipidus: diagnosis and management. Horm Res Paediatr 77(2):69–84
doi: 10.1159/000336333 pubmed: 22433947
Sherwood MC, Stanhope R, Preece MA, Grant DB (1986) Diabetes insipidus and occult intracranial tumours. Arch Dis Child 61(12):1222–1224
doi: 10.1136/adc.61.12.1222 pubmed: 3813614 pmcid: 1778218
Mootha SL, Barkovich AJ, Grumbach MM, Edwards MS, Gitelman SE, Kaplan SL, Conte FA (1997) Idiopathic hypothalamic diabetes insipidus, pituitary stalk thickening, and the occult intracranial germinoma in children and adolescents. J Clin Endocrinol Metab 82(5):1362–1367
pubmed: 9141516
Charmandari E, Brook CGD (1999) 20 years of experience in idiopathic central diabetes insipidus. Lancet 353(9171):2212–2213
doi: 10.1016/S0140-6736(99)00317-7 pubmed: 10392992
Liu W, Wang L, Liu M, Li G (2016) Pituitary morphology and function in 43 children with central diabetes insipidus. Int J Endocrinol. https://doi.org/10.1155/2016/6365830
doi: 10.1155/2016/6365830 pubmed: 27642295 pmcid: 5013240
Maghnie M (2003) Diabeteś insipidus. In: Hormone research, vol 59. S. Karger AG, Basel, pp 42–54
Hannon MJ, Orr C, Moran C, Behan LA, Agha A, Ball SG, Thompson CJ (2012) Anterior hypopituitarism is rare and autoimmune disease is common in adults with idiopathic central diabetes insipidus. Clin Endocrinol 76(5):725–728
doi: 10.1111/j.1365-2265.2011.04270.x
Scherbaum WA, Wass JAH, Besser GM, Bottazzo GF, Doniach D (1986) Autoimmune cranial diabetes insipidus: its association with other endocrine diseases and with histiocytosis X. Clin Endocrinol 25(4):411–420
doi: 10.1111/j.1365-2265.1986.tb01707.x

Auteurs

H Masri Iraqi (HM)

Endocrine Institute, Rabin Medical Center - Beilinson Hospital, 39 Jabotinsky St, Petach Tikva, Israel. iraqihiba@yahoo.com.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. iraqihiba@yahoo.com.

E Pigarova (E)

Endocrinology Research Centre, Moscow, Russia.

S Zacharieva (S)

Medical University Sofia, Sofia, Bulgaria.

A Colao (A)

Federico II University of Naples, Naples, Italy.

L Baraf (L)

Soroka University Medical Center, Beer Sheva, Israel.

M Tsoli (M)

Laiko University Hospital, Athens, Greece.

M Doknic (M)

Neuroendocrine Department, Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

S Ricci Bitti (SR)

University of Genova, Genoa, Italy.

R Giordano (R)

University of Turin, Turin, Italy.

M Barbot (M)

University Hospital of Padova, Padua, Italy.

A Akirov (A)

Endocrine Institute, Rabin Medical Center - Beilinson Hospital, 39 Jabotinsky St, Petach Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

P Witek (P)

Medical University of Warsaw, Warsaw, Poland.

M Serebro (M)

Tel Aviv-Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

M K Auer (MK)

Medizinische Klinik and Poliklinik IV, Klinikum Der Universität München, LMU München, Munich, Germany.

M Tóth (M)

Semmelweis University, Budapest, Hungary.

I Shimon (I)

Endocrine Institute, Rabin Medical Center - Beilinson Hospital, 39 Jabotinsky St, Petach Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH